Clinical Trial Update: Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating AMG 706 in combination with panitumumab and chemotherapy in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• AMG 706 (motesanib)
• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Rectal Cancer, Colon Cancer | Phase 1 | Status: COMPLETED